Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Jan 25, 2023 1:47pm
140 Views
Post# 35245738

RE:RE:RE:RE:RE:RE:RE:RE:RE:Great ... I think...

RE:RE:RE:RE:RE:RE:RE:RE:RE:Great ... I think...Did you not get the latest memo that Spectral has been enrolling 1 patient a month?  And that's during no excuse "historic flu" months. That leaves us with 100 months to go on the Tigris trial.

If this company was doing it's job and enrolling 7+ patients a month, I'd be patiently and quietly sitting back and waiting for our trial results. 

But at 1 a month this trial and the future of this company makes no sense. Period.

The Euphrates PMX trial screened 921 patients and enrolled 450! 

But, that was different management- this gang can't get past 1 per month.

So you can spin whatever nonsense you want- but the numbers are the numbers.
Spectral's only job is to run a trial and get PMX approved. They have proved for 3 years-  this last year without any excuses that they are not able to do it.

P.S. Cheering that we no longer have to pay for the DIMI trial because we no longer have control of DIM- just shows how full of it you are.
<< Previous
Bullboard Posts
Next >>